Feng Xiaoying, Zhao Xin, Cao Lanlan, Shang Ruixue, Feng Xinran
Department of Traditional Chinese Medicine, Xingtai Third Hospital, Xingtai, 054001, Hebei Province, China.
Beijing Tiantongyuan North Community Health Service Center, Changping District, Beijing, 102200, China.
AMB Express. 2024 Nov 8;14(1):123. doi: 10.1186/s13568-024-01783-4.
Peptic ulcers are a prevalent and often chronic condition within the digestive system, frequently prone to recurrence. This study aims to evaluate the clinical effects of Anweiyang capsule combined with Pinellia Heart-Draining Decoction on Helicobacter pylori eradication, ulcer healing rates, and improvement of Traditional Chinese Medicine (TCM) syndromes in patients with peptic ulcers. A total of 100 patients were randomly assigned to an observation group (n = 50), receiving the herbal combination, and a control group (n = 50), receiving standard Western medical treatment. The total effective rate was significantly (P < 0.05) higher in the observation group (96%) compared to the control group (80%). After 4 weeks of treatment, serum procalcitonin (PCT) and C-reactive protein (CRP) levels decreased, while prostaglandin E2 (PGE2) levels increased in both groups; however, the observation group exhibited better results (P < 0.05). The observation group achieved a H. pylori eradication rate of 94% and an ulcer healing rate of 82%, compared to 64% and 56% in the control group, respectively. Improvement in TCM syndrome scores was more significant in the observation group (P < 0.05). Moreover, the incidence of adverse reactions was significantly (P < 0.05) lower in the observation group (4%) compared to the control group (18%). In conclusion, Anweiyang capsule combined with Pinellia Heart-Draining Decoction significantly enhances the eradication rate of H. pylori and the ulcer healing rate without substantially increasing the risk of adverse reactions, demonstrating its safety and reliability for patients.
Cochrane Database Syst Rev. 2016-4-19
Cochrane Database Syst Rev. 2006-4-19
BMC Complement Altern Med. 2017-4-14
Cochrane Database Syst Rev. 2003
Lancet. 2024-7-6
Ulus Travma Acil Cerrahi Derg. 2022-11
Evid Based Complement Alternat Med. 2021-11-12
Nihon Shokakibyo Gakkai Zasshi. 2021
Stem Cell Res Ther. 2021-9-26